킬리안 인터내셔널 홀딩 그룹(BGM)는 NASDAQ에 상장된 Healthcare · Drug Manufacturers - Specialty & Generic 기업입니다. 현재가 $0.29 (-2.45%), 시가총액 $0.06B, 52주 범위 $0.26 ~ $16.36.
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient. The company also provides licorice products, such as Gan Di Xin, a medicine made from raw licorice materials; Qilian Shan licorice extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and
킬리안 인터내셔널 홀딩 그룹의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
킬리안 인터내셔널 홀딩 그룹의 현재 주가는 $0.29 (-2.45%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
킬리안 인터내셔널 홀딩 그룹의 시가총액은 약 $0.06B입니다.
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and t